Pseudomonas aeruginosa bloodstream infections: risk factors and treatment outcome related to expression of the PER-1 extended-spectrum beta-lactamase (Q33236778)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Pseudomonas aeruginosa bloodstream infections: risk factors and treatment outcome related to expression of the PER-1 extended-spectrum beta-lactamase	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

24 July 2017

Pseudomonas aeruginosa bloodstream infections: risk factors and treatment outcome related to expression of the PER-1 extended-spectrum beta-lactamase (English)

1 reference

Europe PubMed Central

24 July 2017

Pseudomonas aeruginosa

1 reference

based on heuristic

inferred from title

Francesco Luzzaro

object named as

Francesco Luzzaro

2

0 references

Antonio Toniolo

object named as

Antonio Q Toniolo

6

0 references

Andrea Endimiani

object named as

Andrea Endimiani

1

1 reference

ORCID Public Data File 2021

Gianfranco Amicosante

object named as

Gianfranco Amicosante

4

1 reference

ORCID Public Data File 2021

Gian Maria Rossolini

5

object named as

Gian Maria Rossolini

1 reference

Europe PubMed Central

24 July 2017

author name string

Beatrice Pini

3

1 reference

Europe PubMed Central

24 July 2017

publication date

16 March 2006

1 reference

Europe PubMed Central

24 July 2017

BMC Infectious Diseases

1 reference

Europe PubMed Central

24 July 2017

6

1 reference

Europe PubMed Central

24 July 2017

52

1 reference

Europe PubMed Central

24 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2334-6-52

0 references

Extended-spectrum beta-lactamases: a clinical update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456971

21 June 2018

Overview of nosocomial infections caused by gram-negative bacilli

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456971

21 June 2018

Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456971

21 June 2018

Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456971

21 June 2018

Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456971

21 June 2018

Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456971

21 June 2018

Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456971

21 June 2018

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456971

21 June 2018

Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase in Northern Italy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456971

21 June 2018

Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456971

21 June 2018

Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456971

21 June 2018

High Prevalence of PER-1 Extended-Spectrum β-Lactamase-Producing Acinetobacter spp. in Korea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456971

21 June 2018

Prevalence and drug susceptibility of pathogens causing bloodstream infections in northern Italy: a two-year study in 16 hospitals.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456971

21 June 2018

Prospective survey of beta-lactamases produced by ceftazidime- resistant Pseudomonas aeruginosa isolated in a French hospital in 2000.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456971

21 June 2018

Emerging extended-spectrum beta-lactamases in Proteus mirabilis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456971

21 June 2018

Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456971

21 June 2018

Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456971

21 June 2018

Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456971

21 June 2018

Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456971

21 June 2018

Sequence analysis of PER-1 extended-spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class A beta-lactamases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456971

21 June 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456971

21 June 2018

CDC definitions for nosocomial infections, 1988

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456971

21 June 2018

Risk factors for antimicrobial resistance and influence of resistance on mortality in patients with bloodstream infection caused by Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-6-52

21 January 2018

A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-6-52

21 January 2018

PER-1 is still widespread in Turkish hospitals among Pseudomonas aeruginosa and Acinetobacter spp.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-6-52

21 January 2018

PER-1 extended-spectrum beta-lactamase production in an Alcaligenes faecalis clinical isolate resistant to expanded-spectrum cephalosporins and monobactams from a hospital in Northern Italy.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-6-52

21 January 2018

Resistance to extended-spectrum cephalosporins, caused by PER-1 beta-lactamase, in Salmonella typhimurium from Istanbul, Turkey.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-6-52

21 January 2018

PER-1 production in a urinary isolate of Providencia rettgeri

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-6-52

21 January 2018

Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-6-52

21 January 2018

Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-6-52

21 January 2018

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-6-52

21 January 2018

PER-1 beta-lactamase-producing Pseudomonas aeruginosa in an intensive care unit

1 reference

https://pubmed.ncbi.nlm.nih.gov/16542460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical importance of extended-spectrum beta-lactamase (PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains

1 reference

https://pubmed.ncbi.nlm.nih.gov/16542460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16542460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activities of cefepime and five other antibiotics against nosocomial PER-1-type and/or OXA-10-type beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter spp

1 reference

https://pubmed.ncbi.nlm.nih.gov/16542460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/16542460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2334-6-52

1 reference

Europe PubMed Central

24 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

24 July 2017

1 reference

Europe PubMed Central

24 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33236778&oldid=1794539889"